GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Wednesday reported a loss of $49.5 million in its fourth quarter.
The Gaithersburg, Maryland-based company said it had a loss of 95 cents per share. Losses, adjusted for one-time gains and costs, were 77 cents per share.
The biopharmaceutical company posted revenue of $276.6 million in the period.
For the year, the company reported a loss of $760.5 million, or $14.85 per share. Revenue was reported as $1.05 billion.
For the current quarter ending in March, Emergent Biosolutions said it expects revenue in the range of $200 million to $250 million.
The company expects full-year revenue in the range of $900 million to $1.1 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
